Risk of Pelvic Inflammatory Disease in Relation to Chlamydia and Gonorrhea Testing, Repeat Testing, and Positivity: A Population-Based Cohort Study
- Chlamydia and Reproductive Health Outcome Investigators
- Curtin University,
- Kirby Institute,
- Melbourne School of Population and Global Health,
- Notre Dame University,
- South Australian Health and Medical Research Institute,
- The University of New South Wales
Open access
Abstract
Background. There is uncertainty around whether the risks of pelvic inflammatory disease (PID) differ following Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea) infection. We quantified the risk of PID associated with chlamydia and gonorrhea infection and subsequent repeat infections in a whole-population cohort. Methods. A cohort of 315 123 Western Australian women, born during 1974-1995, was probabilistically linked to chlamydia and gonorrhea testing records and to hospitalizations and emergency department presentations for PID from 2002 to 2013. Timeupdated survival analysis was used to investigate the association between chlamydia and gonorrhea testing, and positivity, and risk of PID. Results. Over 3 199 135 person-years, 120 748 women had pathology test records for both chlamydia and gonorrhea, 10 745 chlamydia only, and 653 gonorrhea only. Among those tested, 16 778 (12.8%) had ≥1 positive chlamydia test, 3195 (2.6%) ≥1 positive gonorrhea test, and 1874 (1.6%) were positive for both. There were 4819 PID presentations (2222 hospitalizations, 2597 emergency presentations). Adjusting for age, Aboriginality, year of follow-up, health area, and socioeconomic status, compared to women negative for chlamydia and gonorrhea, the relative risk (adjusted incidence rate ratio) of PID was 4.29 (95% confidence interval [CI], 3.66-5.03) in women who were both chlamydia and gonorrhea positive; 4.54 (95% CI, 3.87-5.33) in those only gonorrhea positive; and 1.77 (95% CI, 1.61-1.94) in those only chlamydia positive. Conclusions. Gonorrhea infection conferred a substantially higher risk than chlamydia of hospitalization or emergency department presentation for PID. The emergence of gonorrhea antimicrobial resistance may have a serious impact on rates of PID and its associated reproductive health sequelae.
Research Output Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 437-443 (7 pages)Journal (Volume, Issue Number)
Clinical Infectious Diseases (Volume 66, Issue 3)Publication milestones
- Published - 18/01/2018
Publication status
ISSN
1058-4838Publication IDs
- Scopus: 85041223729
- PubMed: 29136127
Documents and links
Funding Details
Sustainable Development Goals
- SDG 3 Good Health and Well
